Drug resistance in epilepsy

E Perucca, P Perucca, HS White, EC Wirrell - The Lancet Neurology, 2023 - thelancet.com
Drug resistance is estimated to affect about a third of individuals with epilepsy, but its
prevalence differs in relation to the epilepsy syndrome, the cause of epilepsy, and other …

[HTML][HTML] Microglia in epilepsy

C Yu, X Deng, D Xu - Neurobiology of Disease, 2023 - Elsevier
Epilepsy is one of most common chronic neurological disorders, and the antiseizure
medications developed by targeting neurocentric mechanisms have not effectively reduced …

Neurostimulation in people with drug‐resistant epilepsy: systematic review and meta‐analysis from the ILAE surgical therapies commission

L Touma, B Dansereau, AY Chan, N Jetté, CS Kwon… - …, 2022 - Wiley Online Library
Objective Summarize the current evidence on efficacy and tolerability of vagus nerve
stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS) …

[HTML][HTML] Beneficial effects of capsaicin in disorders of the central nervous system

M Pasierski, B Szulczyk - Molecules, 2022 - mdpi.com
Capsaicin is a natural compound found in chili peppers and is used in the diet of many
countries. The important mechanism of action of capsaicin is its influence on TRPV1 …

Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis

HC Skrehot, DJ Englot, Z Haneef - Epilepsy & Behavior, 2023 - Elsevier
Objectives Different neurostimulation modalities are available to treat drug-resistant focal
epilepsy when surgery is not an option including vagus nerve stimulation (VNS), responsive …

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

T Traub-Weidinger, J Arbizu, H Barthel… - European journal of …, 2024 - Springer
Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of
more than 50 million people worldwide and an annual incidence of two million. Although …

Revisiting the concept of drug‐resistant epilepsy: a TASK1 report of the ILAE/AES Joint Translational Task Force

S Auvin, AS Galanopoulou, SL Moshé, H Potschka… - …, 2023 - Wiley Online Library
Despite progress in the development of anti‐seizure medications (ASMs), one third of
people with epilepsy have drug‐resistant epilepsy (DRE). The working definition of DRE …

[HTML][HTML] Targeting NMDA receptor complex in management of epilepsy

S Sivakumar, M Ghasemi, SC Schachter - Pharmaceuticals, 2022 - mdpi.com
N-methyl-D-aspartate receptors (NMDARs) are widely distributed in the central nervous
system (CNS) and play critical roles in neuronal excitability in the CNS. Both clinical and …

[HTML][HTML] Immunity, ion channels and epilepsy

TS Chen, MC Lai, HYI Huang, SN Wu… - International journal of …, 2022 - mdpi.com
Epilepsy is a common chronic neurological disorder in modern society. One of the major
unmet challenges is that current antiseizure medications are basically not disease …

Safety and efficacy of responsive neurostimulation in the pediatric population: evidence from institutional review and patient-level meta-analysis

P Kerezoudis, A Gyftopoulos, AY Alexander… - Epilepsy & Behavior, 2022 - Elsevier
Background Responsive neurostimulation (RNS) is a novel technology for drug-resistant
epilepsy rising from bilateral hemispheres or eloquent cortex. Although recently approved …